An Increasingly Important Alternative for the Treatment of C. Difficile

An Increasingly Important Alternative for the Treatment of C. difficile

Filed under: drug treatment programs maryland

Although current standards set out by the Joint Commission and the National Surgical Quality Improvement Program have effectively decreased the incidence of surgical site infections, they also may have inadvertently caused the emergence of this …
Read more on Gastroenterology & Endoscopy News

Intarcia Supports American Diabetes Association Call For Independent Review …

Filed under: drug treatment programs maryland

Michelle Baron, MD, FACE, Chief Medical Officer of Intarcia, commented on the ADA announcement as well: "Intarcia is committed to and focused on patient safety above all else. For the good of patients and to further scientific knowledge, we pursue the …
Read more on PR Newswire (press release)

US FDA grants orphan drug status to Stemline Therapeutics' SL-401 to treat …

Filed under: drug treatment programs maryland

"We are focused on the rapid development of SL-401 due to its potential for the treatment of IL-3R-expressing hematologic malignancies," commented Eric K Rowinsky, MD, chief medical officer and head of Research and Development at Stemline. "SL-401 is …
Read more on pharmabiz.com